Ian Shakil - May 7, 2024 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
CHIEF STRATEGY OFFICER, Director
Signature
/s/ Todd Holvick, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
May 7, 2024
Transactions value $
-$3,205
Form type
4
Date filed
8/19/2024, 09:38 PM
Previous filing
Apr 16, 2024
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Options Exercise +3.75K +48.69% 11.5K Aug 15, 2024 Direct F1
transaction AUGX Common Stock Tax liability -$3.21K -1.41K -12.33% $2.27 10K Aug 15, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Restricted Stock Units Award $0 +60K +100% $0.00 120K May 7, 2024 Common Stock 60K Direct F1, F2
transaction AUGX Restricted Stock Units Options Exercise $0 -3.75K -3.13% $0.00 116K Aug 15, 2024 Common Stock 3.75K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Augmedix, Inc. (the "Issuer") common stock.
F2 The RSU is granted under the Issuer's 2020 Equity Incentive Plan. One-sixteenth (1/16th) of the RSU will vest quarterly in equal increments over four (4) years commencing on 05/15/2024, with the first one-sixteenth (1/16th) vesting on 08/15/2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F3 Represents an original award of 60,000 RSUs to acquire shares of the Company's common stock. The RSU is granted under the Issuer's 2020 Equity Incentive Plan. One-sixteenth (1/16th) of the RSU will vest quarterly in equal increments over four (4) years commencing on 05/15/2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The RSU award vested with respect to one-sixteenth (1/16th) of the units on 08/15/2024.